Kainos Medicine Inc Cash Flow-to-Debt Ratio
Kainos Medicine Inc cash flow-to-debt ratio. Kainos Medicine Inc (284620) has a Cash Flow-to-Debt Ratio of -0.37x as of March 2025, meaning its operating cash flow of ₩-2.97 Billion could theoretically repay 0% of its total liabilities (₩7.97 Billion) in one year. Check earnings quality score of Kainos Medicine Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Kainos Medicine Inc (2017–2024)
Cash flow-to-debt ratio of Kainos Medicine Inc from 2017 to 2024. Historical debt coverage capacity for Kainos Medicine Inc across 8 annual periods. Check 284620 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Kainos Medicine Inc Cash Flow-to-Debt Ratio by Year (2017–2024)
Kainos Medicine Inc cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Kainos Medicine Inc. For the full cash flow conversion analysis, see Kainos Medicine Inc (284620) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.08x | ₩-9.71 Billion | ₩8.95 Billion | ▲ +29.6% |
| 2023 | -1.54x | ₩-14.22 Billion | ₩9.23 Billion | ▼ -75.5% |
| 2022 | -0.88x | ₩-11.30 Billion | ₩12.87 Billion | ▼ -184.9% |
| 2021 | -0.31x | ₩-9.20 Billion | ₩29.85 Billion | ▲ +9.2% |
| 2020 | -0.34x | ₩-7.61 Billion | ₩22.43 Billion | ▼ -244.3% |
| 2019 | 0.24x | ₩185.74 Million | ₩789.89 Million | ▲ +924.8% |
| 2018 | -0.03x | ₩-22.01 Million | ₩772.06 Million | ▲ +22.5% |
| 2017 | -0.04x | ₩-27.23 Million | ₩740.19 Million | — |